Boston Scientific Income Statement
BSX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Boston Scientific reported $20.1B in revenue and $2.9B in net income for FY2025. Revenue has grown at a 7.2% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.1B | $16.7B | $14.2B | $12.7B | $10.7B | $9.8B | $10.7B | $9.8B | $9.0B | $9.1B | $8.1B | $7.5B | $7.1B | $7.0B | $7.6B |
| Cost of Revenue | $6.2B | $5.3B | $4.3B | $4.0B | $3.1B | $2.8B | $3.1B | $2.8B | $2.6B | $2.4B | $2.2B | $2.2B | $2.2B | $2.3B | $2.7B |
| Gross Profit | $13.9B | $11.5B | $9.9B | $8.7B | $7.6B | $7.0B | $7.6B | $7.0B | $6.5B | $6.0B | $5.3B | $5.2B | $5.0B | $4.9B | $5.0B |
| SG&A Expense | $6.9B | $6.0B | $5.2B | $4.5B | $3.9B | $3.6B | $3.9B | $3.6B | $3.3B | $3.1B | $2.9B | $2.9B | $2.7B | $2.5B | $2.5B |
| R&D Expense | $2.1B | $1.6B | $1.4B | $1.3B | $1.2B | $1.1B | $1.2B | $1.1B | $997.0M | $920.0M | $876.0M | $817.0M | $861.0M | $886.0M | $895.0M |
| Operating Income | $3.6B | $2.6B | $2.3B | $1.6B | $1.5B | $1.5B | $1.5B | $1.5B | $1.3B | $447.0M | -$283.0M | -$301.0M | $120.0M | -$3.9B | $904.0M |
| Interest Expense | $349.0M | $305.0M | $265.0M | $470.0M | $473.0M | $241.0M | $473.0M | $241.0M | $229.0M | $233.0M | $284.0M | $216.0M | $324.0M | $261.0M | $281.0M |
| Income Tax | $493.0M | $436.0M | $393.0M | $443.0M | -$4.0B | -$249.0M | -$4.0B | -$249.0M | $828.0M | -$170.0M | -$411.0M | -$390.0M | -$102.0M | -$39.0M | $201.0M |
| Net Income | $2.9B | $1.8B | $1.6B | $698.0M | $4.7B | $1.7B | $4.7B | $1.7B | $104.0M | $347.0M | -$239.0M | -$119.0M | -$121.0M | -$4.1B | $441.0M |
| EPS (Basic) | $1.96 | $1.26 | $0.69 | $0.45 | $3.38 | $1.21 | $3.38 | $1.21 | $0.08 | -$0.09 | -$0.09 | -$2.89 | $0.29 | -$2.89 | -$0.68 |
| EPS (Diluted) | $1.94 | $1.25 | $0.69 | $0.45 | $3.33 | $1.19 | $3.33 | $1.19 | $0.08 | -$0.09 | -$0.09 | -$2.89 | $0.29 | -$2.89 | -$0.68 |
| Shares Outstanding | 1.5B | 1.5B | 1.4B | 1.4B | 1.4B | 1.4B | 1.4B | 1.4B | 1.4B | 1.3B | 1.3B | 1.3B | 1.4B | 1.4B | 1.5B |
| Gross Margin | 69.0% | 68.6% | 69.5% | 68.8% | 71.0% | 71.4% | 71.0% | 71.4% | 71.3% | 65.7% | 65.7% | 69.3% | 70.3% | 70.4% | 65.1% |
| Operating Margin | 18.0% | 15.5% | 16.4% | 13.0% | 14.1% | 15.3% | 14.1% | 15.3% | 14.2% | 4.9% | -3.5% | -4.0% | 1.7% | -55.6% | 11.9% |
| Profit Margin | 14.4% | 11.0% | 11.2% | 5.5% | 43.8% | 17.0% | 43.8% | 17.0% | 1.1% | 3.8% | -3.0% | -1.6% | -1.7% | -58.5% | 5.8% |